skullcapflavone ii has been researched along with ethidium in 1 studies
| Studies (skullcapflavone ii) | Trials (skullcapflavone ii) | Recent Studies (post-2010) (skullcapflavone ii) | Studies (ethidium) | Trials (ethidium) | Recent Studies (post-2010) (ethidium) |
|---|---|---|---|---|---|
| 18 | 0 | 13 | 4,782 | 11 | 690 |
| Protein | Taxonomy | skullcapflavone ii (IC50) | ethidium (IC50) |
|---|---|---|---|
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 2.0333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhakta, S; Bucar, F; Martin, L; Solnier, J | 1 |
1 other study(ies) available for skullcapflavone ii and ethidium
| Article | Year |
|---|---|
Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.
Topics: Anti-Infective Agents; Bacterial Proteins; Biological Transport; Ethidium; Flavonoids; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Rifampin | 2020 |